About usSign in
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
  • Germany
  • Austria
  • Switzerland
  • Sweden
  • United Kingdom
  • Belgium
  • Denmark
  • Netherlands
  • USA
  • Canada
  • Finland
  • Estonia
  • Latvia
  • Lithuania
  • Luxembourg
  • Spain
  • Czech Republic
  • France
  • Hungary
  • Iceland
  • New Zealand
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
  • Fintech
  • Developer Tools
  • Consumer Health
  • Pharmaceuticals
  • Biotech
About
Atlas Venture has been creating and building breakthrough biotechs for over 30 years. The firm partners with the world's best life science entrepreneurs to translate groundbreaking science into lifechanging medicines. Thirty years at the leadingedge of medical innovation and they’re just getting started.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Atlas Venture focuses on creating and building breakthrough biotechnology companies. They partner with life science entrepreneurs to translate innovation into novel medicines, emphasizing a collaborative, sciencefirst, patientcentric culture.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Owen Hughes – EntrepreneurinResidence

Executive Chairman

Sail Bio

Jason Rhodes – Partner

Kristen Margeson – Vice President of Investor Relations and Marketing

Portfolio

Horizon Pharma

HotSpot Therapeutics

IFM Therapeutics

Ikena Oncology

Intellia Therapeutics

K36 Therapeutics

Kinaset Therapeutics

Korro Bio

Kymera Therapeutics

Lifordi Immunotherapeutics

Lysosomal Therapeutics

Mariana Oncology

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp